Two non-specific melanocortin agonist peptides, bremelanotide and afamelanotide, have been approved for the treatment of hypoactive sexual desire disorder and erythropoietic protoporphyria-associated phototoxicity, respectively, demonstrating the safety of this new drug class
However, those using it for weight loss are generally younger and have higher incomes, while those using it for diabetes tend to have lower incomes
What most articles get wrong about "equivalent doses" The most common error in published conversion guidance is presenting a fixed ratio table (e.g., "Wegovy 1.0 mg = Zepbound 5 mg") without explaining that these are population-level statistical approximations, not individual dose prescriptions
Transl Neurodegener 14(1):10 Trofin D-M et al (2025) Oxidative stress in brain function
In 2025, I have been experimenting with a powerful triangle that is finally moving the needle: Wegovy, Vyvanse and Keto
*Exceeds standard 1 mL (100 unit) insulin syringe capacity This comprehensive table is the core reference for the entire article
